Home Elekta

Elekta

HEDY Group of Guangzhou, China Acquires 10 Elekta Cancer Treatment Systems

Anming Gong, Elekta's Executive Vice President Region China, says the company is addressing the country's need for radiation therapy devices and personnel to operate them.

Uppsala University Hospital First in Sweden to Treat Patient With Elekta Unity Cancer Treatment System

Elekta President and CEO, Richard Hausmann, said: "We are very excited that Uppsala University Hospital, as the first clinic in Sweden, has joined the growing number of cancer clinics around the world providing precision radiation medicine to their patients using the most advanced technology."

International MR-linac Consortium Announced the Launch of the MOMENTUM Study

2/4/19: Information gained through the MOMENTUM study will guide the use of MR/RT to improve outcomes for cancer patients.

Elekta Unity, World’s First High-Field MR-Linac, Receives CE Mark

6/18/18: New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized cancer treatment.

Elekta Focuses on Millimeter Precision and Personalization of Cancer Care at ESTRO 37

4/12/18: With new initiatives in 2018, Elekta is poised to transform the delivery of radiation therapy and the oncology data ecosystem for patient-specific care paths

Elekta’s Leksell Gamma Knife Icon Radiosurgery System Cleared for Use in China

Elekta's Leksell Gamma Knife® Icon™ radiosurgery system has received clearance from the China Food and Drug Administration (CFDA), enabling health care providers in the country to offer this advanced technology to their patients. With stereotactic imaging, automatic delivery correction and dose evaluation for ultra-precise dose delivery, as well as the availability of frameless treatments, Icon is capable of treating virtually any target in the brain, regardless of type, location or volume.